Akorn Shares Rally Following Increased Price Target
Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.
The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.
Shares are currently up 5.25 percent at $34.99.
Latest Ratings for AKRX
|Aug 2016||Deutsche Bank||Downgrades||Buy||Hold|
|Aug 2016||Raymond James||Downgrades||Outperform||Market Perform|
|Mar 2016||Leerink Swann||Maintains||Market Perform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.